LIraglutide and Beta-cell RepAir (LIBRA) Study

This study has been completed.
Sponsor:
Collaborator:
Novo Nordisk A/S
Information provided by (Responsible Party):
Mount Sinai Hospital, Canada
ClinicalTrials.gov Identifier:
NCT01270789
First received: January 4, 2011
Last updated: September 10, 2014
Last verified: September 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2014
  Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)
No publications provided by Mount Sinai Hospital, Canada

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):